- Filed
- May 19, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 45.12M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 95.46M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.4M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.01M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $239.64K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.03M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $18.45M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $9.01M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $3.91M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $2.6M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $8.34M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $7.37M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $12.34M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $11.43M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $12.55M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $12.34M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $30.79M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $20.44M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.06 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.06 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.73M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.48M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $233.75K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $462.06K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.9M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.63M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.85M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.57M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | −$494.65K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $390.66K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $5.46M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $3.05M |
| Revenue | Q1 2026 · Mar 31, 2026 | $4.96M |
| Revenue | Q1 2026 · Mar 31, 2025 | $3.44M |